Advancing therapy for pulmonary arterial hypertension: can animal models help?
Robbins
Ivan M
IM
D000818:Animals; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D011464:Epoprostenol / Q000031:analogs & derivatives* / Q000494:pharmacology*; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000494:pharmacology*; D011687:Purines; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D012680:Sensitivity and Specificity; D000068677:Sildenafil Citrate; D013450:Sulfones; D016896:Treatment Outcome
D010879:Piperazines; D011687:Purines; D013450:Sulfones; C048081:beraprost; D000068677:Sildenafil Citrate; D011464:Epoprostenol